These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 34758409)

  • 1. Techniques to evaluate surfactant activity for a personalized therapy of RDS neonates.
    Autilio C
    Biomed J; 2021 Dec; 44(6):671-677. PubMed ID: 34758409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Noninvasive Surfactant Adsorption Test Predicting the Need for Surfactant Therapy in Preterm Infants Treated with Continuous Positive Airway Pressure.
    Autilio C; Echaide M; Benachi A; Marfaing-Koka A; Capoluongo ED; Pérez-Gil J; De Luca D
    J Pediatr; 2017 Mar; 182():66-73.e1. PubMed ID: 27989413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CPAP failure in the management of preterm neonates with respiratory distress syndrome where surfactant is scarce. A prospective observational study.
    Abdallah Y; Mkony M; Noorani M; Moshiro R; Bakari M; Manji K
    BMC Pediatr; 2023 May; 23(1):211. PubMed ID: 37138252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous positive airway pressure for spontaneously breathing premature infants with respiratory distress syndrome.
    Saxena A; Thapar RK; Sondhi V; Chandra P
    Indian J Pediatr; 2012 Sep; 79(9):1185-91. PubMed ID: 22396227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Harrington EW; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung UltrasouNd Guided surfactant therapy in preterm infants: an international multicenter randomized control trial (LUNG study).
    Corsini I; Rodriguez-Fanjul J; Raimondi F; Boni L; Berardi A; Aldecoa-Bilbao V; Alonso-Ojembarrena A; Ancora G; Aversa S; Beghini R; Meseguer NB; Capasso L; Chesi F; Ciarcià M; Concheiro A; Corvaglia L; Ficial B; Filippi L; Carballal JF; Fusco M; Gatto S; Ginovart G; Gregorio-Hernández R; Lista G; Sánchez-Luna M; Martini S; Massenzi L; Miselli F; Mercadante D; Mosca F; Palacio MT; Perri A; Piano F; Prieto MP; Fernandez LR; Risso FM; Savoia M; Staffler A; Vento G; Dani C
    Trials; 2023 Nov; 24(1):706. PubMed ID: 37925512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new clinical respiratory distress score for surfactant therapy in preterm infants with respiratory distress.
    Nanda D; Nangia S; Thukral A; Yadav CP
    Eur J Pediatr; 2020 Apr; 179(4):603-610. PubMed ID: 31853688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The minimal invasive surfactant therapy: experience from a low resource setting.
    Ajanwaenyi J; Bamidele O; Osim C; Salami O; Umukoro C; Idaboh T; Chimah U; Okolo A
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5177-5183. PubMed ID: 33491516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Rojas-Reyes MX; Morley CJ; Soll R
    Cochrane Database Syst Rev; 2012 Mar; (3):CD000510. PubMed ID: 22419276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant therapy in late preterm and term neonates with respiratory distress syndrome: a systematic review and meta-analysis.
    Ramaswamy VV; Abiramalatha T; Bandyopadhyay T; Boyle E; Roehr CC
    Arch Dis Child Fetal Neonatal Ed; 2022 Jul; 107(4):393-397. PubMed ID: 34686533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant replacement therapy in developing countries.
    Vidyasagar D; Velaphi S; Bhat VB
    Neonatology; 2011; 99(4):355-66. PubMed ID: 21701209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre, randomised trial of preterm infants receiving caffeine and less invasive surfactant administration compared with caffeine and early continuous positive airway pressure (CaLI trial): study protocol.
    Ines F; Hutson S; Coughlin K; Hopper A; Banerji A; Uy C; Finer N; Rich W; Morales A; Steen J; Katheria AC
    BMJ Open; 2021 Jan; 11(1):e038343. PubMed ID: 33483435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of early life endogenous surfactant pool and CPAP failure in preterm neonates with RDS.
    Raschetti R; Centorrino R; Letamendia E; Benachi A; Marfaing-Koka A; De Luca D
    Respir Res; 2019 Apr; 20(1):75. PubMed ID: 30992006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung Ultrasound Score Predicts Surfactant Need in Extremely Preterm Neonates.
    De Martino L; Yousef N; Ben-Ammar R; Raimondi F; Shankar-Aguilera S; De Luca D
    Pediatrics; 2018 Sep; 142(3):. PubMed ID: 30108142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants?
    Tsakalidis C; Giougki E; Karagianni P; Dokos C; Rallis D; Nikolaidis N
    Turk J Pediatr; 2012; 54(4):368-75. PubMed ID: 23692717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RDS-NExT workshop: consensus statements for the use of surfactant in preterm neonates with RDS.
    Bhandari V; Black R; Gandhi B; Hogue S; Kakkilaya V; Mikhael M; Moya F; Pezzano C; Read P; Roberts KD; Ryan RM; Stanford RH; Wright CJ
    J Perinatol; 2023 Aug; 43(8):982-990. PubMed ID: 37188774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RDS--CPAP or surfactant or both.
    Bohlin K
    Acta Paediatr; 2012 Apr; 101(464):24-8. PubMed ID: 22404888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized Medicine for the Management of RDS in Preterm Neonates.
    De Luca D; Autilio C; Pezza L; Shankar-Aguilera S; Tingay DG; Carnielli VP
    Neonatology; 2021; 118(2):127-138. PubMed ID: 33735866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome.
    Ghaemi S; Mohamadymasodi M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.